DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ribavirin (Ribavirin) - Dyspnoea - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Dyspnoea (146)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ribavirin where reactions include dyspnoea. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 146   Next >>

Possible Ribavirin side effects in

Reported by a consumer/non-health professional from United States on 2012-08-24

Patient:

Reactions: White Blood Cell Count Decreased, Dyspnoea, Pruritus Generalised, Fatigue, Dysphonia, Depressed Mood, RED Blood Cell Count Abnormal, Cough

Drug(s) suspected as cause:
Pegasys
    Dosage: 180 microgram, unk
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Dosage: 1000 mg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Victrelis
    Dosage: 4 df, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-10-01

Victrelis
    Dosage: 200 mg, tid

Other drugs received by patient: Pravastatin Sodium; Ambien; Prozac; Vitamin D; Trazodone HCL; Cholecalciferol; Levoxyl; Epoetin Alfa; Neupogen



Possible Ribavirin side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Injection Site Erythema, Dyspnoea, Fatigue, Pruritus, Rash Erythematous, Rash, Thyroid Function Test Abnormal

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-23

Ribavirin
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-23



Possible Ribavirin side effects in 47 year old female

Reported by a health professional (non-physician/pharmacist) from Morocco on 2012-08-23

Patient: 47 year old female

Reactions: Weight Decreased, Angiotensin Converting Enzyme Increased, Subcutaneous Nodule, Aphasia, Coma, Viith Nerve Paralysis, Brain Oedema, Sarcoidosis, Acute Respiratory Failure, Lethargy, Dyspnoea, Neurological Decompensation, Lung Neoplasm, Sensation of Heaviness, Rash, Granuloma, Lymphadenopathy Mediastinal, Cerebral Sarcoidosis, Pleocytosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Dosage: 180 ug, once a week

Ribavirin
    Dosage: 400 mg, bid
    Indication: Hepatitis C

Other drugs received by patient: Prednisolone; Prednisolone; Methylprednisolone



Possible Ribavirin side effects in

Reported by a physician from United States on 2012-08-22

Patient:

Reactions: Metabolic Acidosis, Dyspnoea, Diarrhoea, Hypophagia, Bronchitis, Pyrexia, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Boceprevir
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded MK-5172
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Post Trial Therapy
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded PRE Trial Therapy
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy

Blinded Therapy
    Dosage: f
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy

Blinded Therapy
    Dosage: h
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy
    Dosage: c
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy
    Dosage: g
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy

Blinded Therapy
    Dosage: e
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy
    Dosage: d
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy
    Dosage: b
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy
    Dosage: 4 df, tid
    Administration route: Oral
    Start date: 2012-02-08
    End date: 2012-06-24

Blinded Therapy

Blinded Therapy

Blinded Therapy

Blinded Therapy
    Indication: Hepatitis C

Blinded Therapy

PEG-Intron
    Indication: Hepatitis C

PEG-Intron
    Dosage: 0.5 ml, qw
    Administration route: Oral
    Start date: 2012-01-10
    End date: 2012-06-19

Peginterferon Alfa-2B
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Placebo
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Rebetol
    Dosage: 3 df, qam
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-10

Rebetol
    Dosage: 3 df, qpm
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-06

Rebetol
    Dosage: 2 df, qpm
    Administration route: Oral
    Start date: 2012-04-07
    End date: 2012-06-24

Rebetol
    Dosage: 2 df, qam
    Administration route: Oral
    Start date: 2012-05-01
    End date: 2012-06-24

Rebetol
    Dosage: 3 df, qam
    Administration route: Oral
    Start date: 2012-04-17
    End date: 2012-04-30

Rebetol
    Dosage: 2 df, qam
    Administration route: Oral
    Start date: 2012-04-11
    End date: 2012-04-16

Ribavirin
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Other drugs received by patient: Protonix; Paxil; Protonix; Lisinopril; Paxil; Lisinopril



Possible Ribavirin side effects in

Reported by a physician from United States on 2012-08-22

Patient:

Reactions: Fatigue, Dyspnoea, Pruritus, Injection Site Erythema, Rash Erythematous, Rash, Thyroid Function Test Abnormal

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-23

Ribavirin
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-23



Possible Ribavirin side effects in

Reported by a physician from United States on 2012-08-20

Patient:

Reactions: Weight Increased, Dysgeusia, Dyspnoea, Fatigue, Nausea, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2011-07-18

Ribavirin
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2011-07-18
    End date: 2011-12-26

Victrelis
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2011-08-24
    End date: 2011-12-23

Other drugs received by patient: Methotrexate



Possible Ribavirin side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20

Patient: male

Reactions: Abdominal Pain, Dyspnoea, Ileus

Adverse event resulted in: death

Drug(s) suspected as cause:
Cozaar
    Indication: Product Used FOR Unknown Indication

Pegasys
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Incivek



Possible Ribavirin side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-20

Patient: female

Reactions: Staphylococcal Skin Infection, Cellulitis, Viral Load Increased, Dyspnoea, Arthropathy, Renal Failure, Alopecia, Abscess, Cough

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Incivek
    Indication: Hepatitis C
    Start date: 2012-02-03

Pegasys
    Indication: Hepatitis C
    Start date: 2012-02-03

Ribavirin
    Indication: Hepatitis C
    Start date: 2012-02-03



Possible Ribavirin side effects in

Reported by a consumer/non-health professional from United States on 2012-08-17

Patient:

Reactions: White Blood Cell Count Decreased, Weight Decreased, Dyspnoea, Nausea, Diabetes Mellitus, Hypotension, Anaemia, Rash, Headache, Therapeutic Product Ineffective, Dysgeusia, Fatigue, RED Blood Cell Count Decreased, Asthenia, Lethargy, Epistaxis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2008-01-04
    End date: 2008-10-03

PEG-Intron
    Dosage: unk unk, unknown
    Start date: 2011-08-17
    End date: 2012-04-03

PEG-Intron
    Dosage: unk unk, unknown
    End date: 2009-10-07

PEG-Intron
    Dosage: 0.4 ?g, unknown

PEG-Intron
    Dosage: 0.3 ?g, unknown

Ribavirin
    Dosage: unk unk, unknown
    End date: 2009-10-07

Ribavirin
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2008-01-04
    End date: 2008-10-03

Ribavirin
    Dosage: 200 mg, qd

Ribavirin
    Dosage: unk unk, qd

Ribavirin
    Dosage: unk unk, qd
    Start date: 2011-08-17
    End date: 2012-04-03

Ribavirin

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-09-14

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Start date: 2011-09-14

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Start date: 2011-09-14

Other drugs received by patient: Epoetin Alfa



Possible Ribavirin side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-13

Patient: female

Reactions: Blood Iron Decreased, Drug Dose Omission, Dyspnoea, RED Blood Cell Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Indication: Hepatitis C
    Start date: 2012-07-05

Ribavirin
    Indication: Hepatitis C
    Start date: 2012-07-05

Telaprevir
    Indication: Hepatitis C
    Start date: 2012-07-05

Other drugs received by patient: Warfarin Sodium; Fluoxetine HCL; Metformin Hydrochloride; Bisacodyl; Trazodone Hydrochloride; Ferrous Sulfate TAB



Possible Ribavirin side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient:

Reactions: Abdominal Pain, Dyspnoea, Ileus

Adverse event resulted in: death

Drug(s) suspected as cause:
Cozaar
    Indication: Product Used FOR Unknown Indication

Pegasys
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Telaprevir



Possible Ribavirin side effects in female

Reported by a individual with unspecified qualification from United States on 2012-08-10

Patient: female, weighing 72.5 kg (159.5 pounds)

Reactions: Dyspnoea, Rash, Stevens-Johnson Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2012-05-07

Placebo
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-07
    End date: 2012-07-18

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-07

VX-950
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-07
    End date: 2012-07-18

Other drugs received by patient: Metrogel; Equate Allergy Relief; Tylenol; Multi-Vitamins; Tramadol HCL; Gold Bond Intensive Healing Cream; GAS-X



Possible Ribavirin side effects in male

Reported by a consumer/non-health professional from Germany on 2012-08-10

Patient: male

Reactions: Dyspnoea, Chills, Headache, Somnolence, Cardiac Disorder, Apathy, Memory Impairment, Asthenia

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2012-06-01

Ribavirin
    Indication: Hepatitis C
    Start date: 2012-06-01

Telaprevir
    Indication: Hepatitis C
    Start date: 2012-06-01



Possible Ribavirin side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-07

Patient:

Reactions: Dyspnoea, Fatigue

Drug(s) suspected as cause:
Pegasys
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-01

Ribavirin
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-01

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-01



Possible Ribavirin side effects in

Reported by a physician from United States on 2012-08-07

Patient:

Reactions: Dyspnoea, Nausea, Palpitations, DRY Mouth, Decreased Appetite

Drug(s) suspected as cause:
Pegasys

Ribavirin
    Dosage: 1200, qd

Victrelis
    Dosage: 200 mg, unk

Other drugs received by patient: Prednisone



Possible Ribavirin side effects in female

Reported by a individual with unspecified qualification from United States on 2012-08-03

Patient: female, weighing 72.5 kg (159.5 pounds)

Reactions: Dyspnoea, Rash, Stevens-Johnson Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2012-05-07

Placebo
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-07
    End date: 2012-07-18

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-07

VX-950
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-07
    End date: 2012-07-18

Other drugs received by patient: Tylenol (Caplet); Tramadol HCL; Equate Allergy Relief; Metrogel; Multi-Vitamins; GAS-X; Gold Bond Intensive Healing Cream



Possible Ribavirin side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03

Patient:

Reactions: Weight Decreased, Head Injury, Teeth Brittle, Loss of Consciousness, Malaise, Fatigue, Oral Candidiasis, Hyperchlorhydria, Depression, Decreased Appetite, Hypersomnia, Tooth Fracture, Dyspnoea, Vomiting, Anaemia, Rash, Dysgeusia, Anxiety, Alopecia, Insomnia, Hypophagia, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2011-10-25

Ribavirin
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2011-10-25

Victrelis
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2011-11-23



Possible Ribavirin side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-01

Patient: female

Reactions: Abdominal Pain, Thrombosis, Pruritus, Lymphadenopathy, Injection Site Haematoma, Hallucination, Auditory, Tooth Extraction, Headache, Appetite Disorder, Malaise, Menorrhagia, Skin Warm, Muscle Spasms, Blister, Crying, Back Pain, Stomatitis, Rash Erythematous, Insomnia, Swelling, Vision Blurred, Thyroid Disorder, Pain, Constipation, Fatigue, Chest Pain, Bone Disorder, Depression, Hallucination, Decreased Appetite, Blood Pressure Increased, Dyspnoea, Nausea, Musculoskeletal Pain, Rash, Anxiety, Gingival Pain, Psychotic Disorder, Lung Disorder, Oral Pain, Dysuria, Pollakiuria, Memory Impairment, Feeling Abnormal

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2004-10-30
    End date: 2005-01-09

Pegasys

Pegasys
    Dosage: dosage reported as one injection per week.
    Indication: Hepatitis C
    Start date: 2004-10-30
    End date: 2005-01-09

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C

Telaprevir
    Indication: Hepatitis C

Other drugs received by patient: Wellbutrin; Prozac



Possible Ribavirin side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-30

Patient: male

Reactions: Dysgeusia, Dyspnoea, Coagulopathy, Pulmonary Thrombosis, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2012-05-22

Ribavirin
    Indication: Hepatitis C
    Start date: 2012-05-22



Possible Ribavirin side effects in

Reported by a physician from United States on 2012-07-18

Patient:

Reactions: Dyspnoea, Blood Potassium Decreased, Anaemia, Abasia, Depression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-27
    End date: 2012-06-01

Ribavirin
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-27
    End date: 2012-06-01

Telaprevir
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-27
    End date: 2012-06-01



Possible Ribavirin side effects in

Reported by a physician from United States on 2012-07-18

Patient:

Reactions: Dyspnoea, Fatigue

Drug(s) suspected as cause:
Pegasys

Ribavirin

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-01



Possible Ribavirin side effects in male

Reported by a individual with unspecified qualification from United States on 2012-07-17

Patient: male

Reactions: Fatigue, Dyspnoea, Pruritus, Injection Site Erythema, Rash, Thyroid Function Test Abnormal

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-23

Ribavirin
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-23



Possible Ribavirin side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-13

Patient: male

Reactions: Dyspnoea, Dehydration, Dizziness, Ill-Defined Disorder, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2012-04-20

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-20

Telaprevir
    Indication: Hepatitis C
    Start date: 2012-04-20
    End date: 2012-07-05



Possible Ribavirin side effects in 57 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13

Patient: 57 year old female, weighing 85.7 kg (188.6 pounds)

Reactions: Night Sweats, White Blood Cell Count Decreased, Dyspnoea, Wheezing, Chills, Haemorrhoids, Anaemia, Laceration, Pyrexia, Joint Stiffness, Fatigue, Diverticulum, RED Blood Cell Count Decreased, Arthralgia, Impaired Healing, Insomnia, Dizziness, Injury, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 180 mcg once a week
    Indication: Hepatitis C

Pegasys
    Dosage: 180 mcg once a week
    Indication: Hepatitis C

Ribavirin
    Dosage: 1200 mg/day, 1000 mg daily (400 mg am and 600 mg pm)
    Indication: Hepatitis C
    Start date: 2011-09-04

Ribavirin
    Dosage: 1200 mg/day, 1000 mg daily (400 mg am and 600 mg pm)
    Indication: Hepatitis C
    Start date: 2011-11-07

Victrelis
    Dosage: 200 mg 4 tabs three times a day orally
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-21

Other drugs received by patient: Echinacea; Citalopram Hydrobromide; Milk Thistle; Zolpidem; Vitamin E; Omeprazole; Allegra-D 12 Hour



Possible Ribavirin side effects in 52 year old female

Reported by a consumer/non-health professional from United States on 2012-07-05

Patient: 52 year old female

Reactions: Dyspnoea, Fall, Device Malfunction, Asthenia, Blood Pressure Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 mcg; qw
    Indication: Hepatitis C
    Start date: 2012-05-01

Ribavirin
    Indication: Hepatitis C

Other drugs received by patient: Tranxene; Zofran; Synthroid; Effexor; Lisinopril; Paxil CR



Possible Ribavirin side effects in 56 year old male

Reported by a consumer/non-health professional from United Kingdom on 2012-07-04

Patient: 56 year old male, weighing 65.8 kg (144.7 pounds)

Reactions: Drug Dose Omission, White Blood Cell Count Decreased, Chest Discomfort, Dyspnoea, Decreased Activity, Musculoskeletal Pain, Rash, Headache, Full Blood Count Decreased, Haemoglobin Decreased, Fatigue, Affect Lability, Heart Rate Increased, Dizziness, Asthenia

Drug(s) suspected as cause:
Neupogen
    Dosage: unk unk, 2 times/wk
    Indication: White Blood Cell Count Decreased
    Start date: 2011-04-29

Peginterferon Alfa-2A
    Dosage: 180 mug, qwk
    Indication: Hepatitis C
    Start date: 2010-11-26

Ribavirin
    Dosage: 1200 mg, qd
    Indication: Hepatitis C
    Start date: 2010-11-26

Ribavirin
    Dosage: 1000 mg, qd



Possible Ribavirin side effects in 56 year old female

Reported by a physician from United States on 2012-07-03

Patient: 56 year old female

Reactions: Weight Decreased, Capsule Physical Issue, Dyspnoea, Nausea, Anaemia, Headache, Rash, Dysgeusia, Fatigue, Asthenia, Lethargy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.4 mcg ; 0.3 mcg
    Indication: Hepatitis C
    Start date: 2008-01-04
    End date: 2008-10-03

PEG-Intron
    Dosage: 0.4 mcg ; 0.3 mcg
    Indication: Hepatitis C
    End date: 2008-10-07

PEG-Intron
    Dosage: 0.4 mcg ; 0.3 mcg
    Indication: Hepatitis C
    Start date: 2011-08-17
    End date: 2012-04-30

Ribavirin
    Dosage: qd ; qd; 200 mg;qd
    Indication: Hepatitis C
    End date: 2009-10-07

Ribavirin
    Dosage: qd ; qd; 200 mg;qd
    Indication: Hepatitis C
    Start date: 2011-08-17
    End date: 2012-04-03

Ribavirin
    Dosage: qd ; qd; 200 mg;qd
    Indication: Hepatitis C
    Start date: 2008-01-04
    End date: 2008-10-03

Victrelis
    Dosage: 800 mg;tid;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-09-14

Other drugs received by patient: Procrit



Possible Ribavirin side effects in 44 year old female

Reported by a physician from Australia on 2012-07-03

Patient: 44 year old female, weighing 54.0 kg (118.8 pounds)

Reactions: Fatigue, Haematocrit Decreased, Pharyngeal Oedema, Vitreous Floaters, Dizziness, White Blood Cell Count Decreased, Back Pain, Dyspnoea, Swelling Face, Ill-Defined Disorder, Tremor, Haemoglobin Decreased, Vision Blurred, Neutropenia, Asthenia, Neutrophil Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
GS-5885 (Investigational Drug)
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-25
    End date: 2012-03-31

GS-9451 (Investigational Drug)
    Dosage: 200 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-25
    End date: 2012-03-31

Peginterferon Alfa-2A
    Dosage: 180 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2012-01-25
    End date: 2012-03-28

Ribavirin
    Dosage: 1000 mg;qw;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-25
    End date: 2012-03-31

Other drugs received by patient: Lysine; Pinetarsol; Cypromeptadine; Acidophilis; Loratadine; Metoclopranide; Mintec; Acetaminophen; Eumovate; Phenergan HCL; Arerius; Polaramine



Possible Ribavirin side effects in male

Reported by a consumer/non-health professional from United States on 2012-06-29

Patient: male

Reactions: Nerve Injury, Cystitis Radiation, Pain, Cyst, Fatigue, Emotional Disorder, Pain in JAW, Abdominal Pain Lower, Back Pain, Dyspnoea, Blood Urine Present, Musculoskeletal Discomfort, Joint Injury, Full Blood Count Decreased, Irritability, Haemoglobin Decreased, Syncope, Arthralgia, Insomnia

Drug(s) suspected as cause:
Boceprevir
    Indication: Hepatitis C
    Start date: 2011-12-12

Pegasys
    Indication: Hepatitis C
    Start date: 2011-11-13

Ribavirin
    Dosage: dose reduced
    Administration route: Oral
    Start date: 2012-01-25

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-13



Possible Ribavirin side effects in 64 year old female

Reported by a pharmacist from United States on 2012-06-28

Patient: 64 year old female

Reactions: Dyspnoea, Hypocalcaemia, Gait Disturbance, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Dosage: 180mcg qw sq
    Indication: Hepatitis C
    Start date: 2012-03-16
    End date: 2012-06-17

Ribavirin
    Dosage: 600mg bid po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-15
    End date: 2012-06-17



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012